Home > Cancer and Treatments > Pancreatic Cancer > Research
The Laboratory of Dr. Charles F. Burant
University of Michigan
The Burant lab focuses on the study of Diabetes, with on-going research in many areas.
The lab is interested in identifying the ways in which nutrients, drugs and biologics affect insulin sensitivity
and the way that they lead to Type II Diabetes. They are evaluating these affects through clincal research,
utilizing animal models of diabetes and insulin sensitivity, and through studying the underlying cellular pathways
of energy metabolism.
Additionally, the Burant lab is interested in studying how new ß-cells can be generated ex vivo for the treatment
of both Type I and II Diabetes. They are utilizing novel techniques to prospectively isolate and differentiate adult
pancreatic stem/progenitor cells into multiple pancreatic lineages.
Visit the Burant Lab
The Lab of Craig D. Logsdon, Ph.D.
The University of Texas
MD Anderson Cancer Center
The goal of the Logsdon laboratory is to improve the diagnosis and treatment of pancreatic cancer and the related
disease pancreatitis. The strategy the lab employs involves several steps: 1) Discovery; 2) Validation;
3) Functional Characterization; and, 4) Experimental therapeutic application.
Using this approach the lab has already discovered important biomarkers and exciting candidates for therapeutic
intervention. However, there are many more candidate molecules to investigate and much more to discover. This is a
very exciting time for research into pancreatic disease with many opportunities for collaborative research.
Read about Dr. Logsdon's
research interests.
View Dr. Logsdon's
publications.
The Lab of Dr. David M. Lubman
University of Michigan
The Lubman Laboratory is involved in developing novel biotechnologies to solve difficult biological problems. The
focus of the work has been in the field of Proteomics and Cancer Research. Proteomics involves the study of the
protein expression of a cell, where proteins are the entities that perform the functions of the cell. The labs
work has involved developing methods to profile large numbers of proteins expressed by cancer cells and to understand
how these proteins are different than those observed from normal cells. Proteins that are modified or overexpressed
in cancer cells often result in new protein pathways that lead to tumorogenesis and metastasis of the cancer.
Visit the Lubman Lab
Return to the top of the page
